Overview

Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor

Status:
Unknown status

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

Studies showed that combined use of clopidogrel and aspirin had a 25 % reduction of risk on myocardial infarction and stroke in patients who undergone percutaneous coronary intervention (PCI) when compared with use of aspirin alone. However, major GI bleeding rose in combined group than aspirin group. Use of proton pump inhibitor (PPI) which diminishes gastric acid secretion effectively reduces aspirin or clopidogrel associated ulcer or/and ulcer bleeding in general population and high risk patients. The investigator hypothesis is whether use of PPI can reduce ulcer and ulcer complication in patients taking both clopidogrel and aspirin.

Phase:

N/A

Details

Lead Sponsor:

Taipei Veterans General Hospital, Taiwan

Treatments:

Aluminum Hydroxide
Aspirin
Clopidogrel
Dexlansoprazole
Lansoprazole
Proton Pump Inhibitors